Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Zogenix to seek FDA approval of chronic-pain drug
Marketwatch
Wednesday, August 17, 2011 - 9:03am
tags:
FDA, Zogenix, chronic pain, Zohydro
Perrigo Profit Up 44%, But Sales Miss
Yahoo/InvestorsBusinessDaily
Wednesday, August 17, 2011 - 9:02am
tags:
earnings, Perrigo Company
Is China preparing to challenge the U.S. for biotech supremacy?
Fierce Biotech
Wednesday, August 17, 2011 - 8:57am
tags:
China, biotech
Array Represents a Great Opportunity for Very Patient Investors
Seeking Alpha
Wednesday, August 17, 2011 - 8:54am
tags:
Array Biopharma
Viagra Ruling Gives Boost to Pfizer Salesforce
FINS/WSJ Online
Wednesday, August 17, 2011 - 8:52am
tags:
patents, Viagra, Pfizer, drug reps, erectile dysfunction
Regeneron Says FDA Delays Eylea Drug for Blindness
Bloomberg
Wednesday, August 17, 2011 - 8:27am
tags:
Regeneron, FDA, blindness, Eylea, Lucentis, Roche
Cytos Plunges as Research Halted, Workforce Slashed, Chief Quits
Bloomberg
Wednesday, August 17, 2011 - 8:26am
tags:
Cytos Biotechnology, layoffs
Abbott Labs says FDA approves longer-acting Lupron
Yahoo/AP
Wednesday, August 17, 2011 - 8:25am
tags:
FDA, Lupron, Abbott Laboratories, central precocious puberty
Endo Pharmaceuticals Sues Mylan in Delaware Court Over Frova Generic Drug
Bloomberg
Tuesday, August 16, 2011 - 6:28pm
tags:
Endo, Mylan, generics, Frova, Delaware, migraines
Merck Favors Alliances Over Headcount to Tap China Growth
Bloomberg
Tuesday, August 16, 2011 - 6:26pm
tags:
Merck, China
Sanofi Aventis: A High Yielding Pharma Stock With a Low Valuation
Seeking Alpha
Tuesday, August 16, 2011 - 6:25pm
tags:
Sanofi
Abbott Labs says it will build $230M powdered milk manufacturing facility in China
Yahoo/AP
Tuesday, August 16, 2011 - 6:23pm
tags:
Abbott Laboratories, infant formula, China
CEO urges Icagen shareholders to approve company’s sale to Pfizer
Bizjournals.com
Tuesday, August 16, 2011 - 12:22pm
tags:
Pfizer, shareholders, M&A, Icagen
Icahn funds unload stakes in Biogen, Amgen
Fierce Pharma
Tuesday, August 16, 2011 - 11:12am
tags:
Biogen Idec, Amgen, Carl Icahn
EpiCept is on track to achieve 2011 goals
Yahoo/Zacks.com
Tuesday, August 16, 2011 - 10:55am
tags:
earnings, EpiCept
Pharma’s Influence on the Super Committee: Is Cash Really King?
PharmExec
Tuesday, August 16, 2011 - 10:06am
tags:
deficit, pharma industry
Take a Chance on Dendreon Corp
Seeking Alpha
Tuesday, August 16, 2011 - 10:05am
tags:
Dendreon, Provenge, prostate cancer
Ampio Pharmaceuticals' Bevy of Repositioned Products Could Make a Splash in Health Care
Seeking Alpha
Tuesday, August 16, 2011 - 10:04am
tags:
Ampion Pharmaceuticals, Ampio Pharmaceuticals, Optina, Zertane
Simcere Pharma Beats on Bottom Line
Yahoo/Zacks.com
Tuesday, August 16, 2011 - 9:31am
tags:
earnings, Simcere
Bullish on Optimer Pharma
Yahoo/Zacks.com
Tuesday, August 16, 2011 - 8:22am
tags:
Optimer, antibiotics, Dificid, Clostridium Difficile, Cubist Pharmaceuticals, ViroPharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.